CIK: 0001582844 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $214,028 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 554,000 | $28,149 | 13.2% | $38.98 | +13.3% | COM | 03753U106 |
| WHWK | AADI BIOSCIENCES INC | 1,529,402 | $25,954 | 12.1% | $30.48 | -37.1% | COM | 00032Q104 |
| — | VISTAGEN THERAPEUTICS INC | 11,736,283 | $14,553 | 6.8% | $2.01 | — | COM NEW | 92840H202 |
| CLDX | CELLDEX THERAPEUTICS INC | 322,898 | $10,998 | 5.1% | $7.56 | +322.9% | COM NEW | 15117B202 |
| RLMD | RELMADA THERAPEUTICS INC | 342,000 | $9,231 | 4.3% | $22.24 | -7.0% | COM | 75955J402 |
| — | IVERIC BIO INC | 539,500 | $9,080 | 4.2% | $7.54 | — | COM | 46583P102 |
| — | BCLS ACQUISITION CORP- CL A | 843,122 | $8,322 | 3.9% | $11.14 | — | COM CL A | G0904B105 |
| GHRS | GH RESEARCH PLC | 419,632 | $7,675 | 3.6% | $20.48 | -13.8% | ORDINARY SHARES | G3855L106 |
| KURA | KURA ONCOLOGY INC. COMMON STOCK | 473,969 | $7,621 | 3.6% | $15.11 | -4.5% | COM | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 225,000 | $6,878 | 3.2% | $15.28 | +95.9% | COM | 98420N105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 340,000 | $6,287 | 2.9% | $17.08 | +12.5% | COM | 92790C104 |
| — | MERUS NV | 235,500 | $6,227 | 2.9% | $26.72 | — | COM | N5749R100 |
| — | BELLUS HEALTH INC | 816,000 | $5,614 | 2.6% | $6.40 | — | COM NEW | 07987C204 |
| — | JOUNCE THERAPEUTICS INC | 813,500 | $5,524 | 2.6% | $7.04 | — | COM | 481116101 |
| — | JIYA ACQUISITION CORP -CL A | 562,500 | $5,524 | 2.6% | $10.30 | — | COM CL A | 47760M102 |
| FULC | FULCRUM THERAPEUTICS INC | 200,000 | $4,730 | 2.2% | $11.72 | +20.8% | COM | 359616109 |
| — | MIRATI THERAPEUTICS | 52,500 | $4,317 | 2.0% | $106.79 | — | COM | 60468T105 |
| — | AVADEL PHARMACEUTICALS PLC | 580,000 | $3,961 | 1.9% | $6.83 | — | SPONSORED ADR | 05337M104 |
| — | HEALTH SCIENCES ACQUISITIONS | 392,500 | $3,890 | 1.8% | $11.00 | — | ORD SHS | G4411D109 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 82,500 | $3,794 | 1.8% | $43.08 | +14.9% | COM | 04280A100 |
| ACRS | ACLARIS THERAPEU | 217,600 | $3,751 | 1.8% | $16.31 | -16.3% | COM | 00461U105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 307,944 | $3,742 | 1.7% | $11.19 | -2.1% | COM NEW | 30233G209 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 206,126 | $3,582 | 1.7% | $17.89 | -5.9% | COM | 87164F105 |
| — | HORIZON THERAPEUTICS PLC | 33,200 | $3,493 | 1.6% | $105.21 | — | SHS | G46188101 |
| PMVP | PMV PHARMACEUTICALS INC | 135,500 | $2,821 | 1.3% | $17.64 | 0.0% | COM | 69353Y103 |
| — | HARPOON THERAPEUTICS INC | 497,500 | $2,473 | 1.2% | $4.97 | — | COM | 41358P106 |
| MIST | MILESTONE PHARMACEUTICALS IN | 380,000 | $2,440 | 1.1% | $6.25 | 0.0% | COM | 59935V107 |
| PMVP | CALL- PMVP 100 @ 20 EXP 06/17/2022 | 100,000 | $2,082 | 1.0% | $17.64 | 0.0% | Call | 69353Y103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 118,856 | $1,979 | 0.9% | $21.92 | -29.5% | COM | 462260100 |
| — | ATHIRA PHARMA INC | 140,030 | $1,890 | 0.9% | $18.82 | — | COM | 04746L104 |
| — | VERASTEM INC | 996,951 | $1,406 | 0.7% | $2.55 | — | COM | 92337C104 |
| — | CALL- ATHA 100@12 1/2 EXP 07/15/2022 | 100,000 | $1,350 | 0.6% | $18.82 | — | Call | 04746L104 |
| — | MOLECULAR TEMPLATES INC | 307,125 | $1,060 | 0.5% | $3.92 | — | COM | 608550109 |
| VTYX | VENTYX BIOSCIENCES INC | 70,877 | $962 | 0.4% | $13.36 | 0.0% | COM | 92332V107 |
| PYXS | PYXIS ONCOLOGY INC | 200,000 | $808 | 0.4% | $11.45 | -36.2% | COMMON STOCK | 747324101 |
| — | DICE THERAPEUTICS INC | 37,500 | $717 | 0.3% | $19.12 | — | COM | 23345J104 |
| ACIU | CALL- ACIU 100@7 1/2EXP 08/19/2022 | 100,000 | $400 | 0.2% | — | — | Call | H00263105 |
| — | IMMUNOGEN INC | 55,000 | $262 | 0.1% | $4.76 | — | COM | 45253H101 |
| — | SEELOS THERAPEUTICS INC | 295,896 | $248 | 0.1% | $4.05 | — | COM | 81577F109 |
| ENTA | ENANTA PHARMACEUTICALS INC | 2,300 | $164 | 0.1% | $65.07 | 0.0% | COM | 29251M106 |
| NUVB | NUVATION WARRANTS | 90,832 | $69 | 0.0% | $9.19 | -38.9% | *W EXP 07/07/202 | 67080N101 |